Speaker Profile
Ph.D., Co-founder and CEO, Omabit
Biography
Elena Arzumanyan, PhD, is Co-founder and CEO of Omabit, a biotechnology company developing AI-powered tools to make complex genomic and clinical data analysis accessible to life sciences researchers. She holds a PhD in Molecular Biology from Lomonosov Moscow State University and brings extensive experience in molecular diagnostics, assay development, and biotechnology entrepreneurship. Previously, she co-developed an early cancer detection assay covering nine cancers at Avida Biomed, which was acquired by Agilent Technologies, and led rare disease assay development at Natera. At Omabit, she focuses on applying artificial intelligence to integrate genomic and clinical evidence, accelerate biomarker discovery, and support more informed drug development decisions. Omabit is part of the StartX Summer 2026 founder community.
AI and Data Sciences Showcase:
Omabit
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
